Medicine & Life Sciences

1. Granulomatosis with Polyangiitis 100%
2. Vasculitis 92%
3. Giant Cell Arteritis 77%
4. Myositis 55%
5. Antineutrophil Cytoplasmic Antibodies 55%
6. Dermatomyositis 43%
7. Takayasu Arteritis 42%
8. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 36%
9. Myeloblastin 28%
10. Rituximab 28%
11. Rheumatoid Arthritis 21%
12. Remission Induction 20%
13. Rheumatic Diseases 19%
14. tofacitinib 18%
15. Biomarkers 17%
16. Rheumatology 16%
17. Genome-Wide Association Study 16%
18. Microscopic Polyangiitis 16%
19. Cohort Studies 14%
20. Systemic Vasculitis 14%
21. Cyclophosphamide 14%
22. Etanercept 13%
23. Antibodies 12%
24. Prednisone 12%
25. Inclusion Body Myositis 12%
26. Recurrence 12%
27. Abatacept 11%
28. Serum 11%
29. Polyarteritis Nodosa 10%
30. Muscles 10%
31. Orthotic Devices 10%
32. Interferons 10%
33. Therapeutics 10%
34. Biopsy 9%
35. Clinical Trials 9%
36. Incidence 9%
37. Arteritis 8%
38. Alleles 8%
39. Arthritis 8%
40. Systemic Lupus Erythematosus 8%
41. Enterovirus 8%
42. Population 7%
43. Herpes Zoster 7%
44. Chemokines 7%
45. Wrist 7%
46. Venous Thromboembolism 7%
47. Immunoglobulin A 7%
48. Autoantibodies 7%